Estimation of PI‐bound proteins on blood cells from PNH patients by quantitative flow cytometry
- 1 August 1990
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 75 (4) , 585-590
- https://doi.org/10.1111/j.1365-2141.1990.tb07803.x
Abstract
Summary. The phosphatidylinositol (PI) bound proteins (acetylcholin‐esterase (ACE), decay accelerating factor (DAF), leucocyte function antigen type 3 (LFA‐3) and Fc‐receptor type III (FcRIII)) were estimated by flow cytometry on blood cells from four patients with paroxysmal nocturnal haemoglobinuria (PNH), nine patients with ‘non‐PNH’haemolytic anaemia, four patients with aplastic anaemia and a reference group of 15 healthy individuals to assess the applicability of flow cytometric measurements in the clinical mapping of the PNH defect. Estimation of DAF on granulocytes or monocytes offered the highest diagnostic sensitivity and specificity and may constitute an easy screening method for the PNH defect. One PNH patient had a negative Ham's test at the time of study and normal or near normal levels of PI‐bound proteins on erythrocytes, but reduced expression of DAF and FcRIII on granulocytes and DAF on monocytes. The analytical and biological coefficient of variation for flow cytometric estimation of PI‐bound proteins was in the range of 4.8‐13% and 12‐24%, respectively. Blood samples should be analysed without delay, since storage produced spuriously high results. The results were expressed as molecules per cell after calibration with commercially available standards and validated by comparison with previously reported results obtained by other methods. It is proposed that this way of reporting flow cytometric results should be generally adopted to facilitate comparison of results between laboratories.Keywords
This publication has 15 references indexed in Scilit:
- The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuriaNature, 1988
- Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor.The Journal of Experimental Medicine, 1987
- Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.Journal of Clinical Investigation, 1987
- Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1987
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.The Journal of Experimental Medicine, 1986
- Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodiesJournal of Immunological Methods, 1985
- A new standard fluorescence microsphere for quantitative flow cytometryJournal of Immunological Methods, 1985
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1985
- Deficiency of the Complement Regulatory Protein, Decay-Accelerating Factor, on Membranes of Granulocytes, Monocytes, and Platelets in Paroxysmal Nocturnal HemoglobinuriaNew England Journal of Medicine, 1985
- Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation.The Journal of cell biology, 1983